Cabaletta Bio Inc

NASDAQ:CABA   3:59:44 PM EDT
9.42
+0.28 (+3.06%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Cabaletta Bio Inc Stock, NASDAQ:CABA

2929 Arch Street, Suite 600, Philadelphia, Pennsylvania 19104
United States of America
Phone: +1.267.759.3100
Number of Employees: 34

Description

Cabaletta Bio, Inc. operates as a clinical-stage biotechnology company, which engages in the discovery and development of engineered T cell therapies for B cell-mediated autoimmune diseases. Its proprietary technology utilizes chimeric autoantibody receptor to selectively bind and eliminate B cells that produce disease-causing autoantibodies. The company was founded by Michael C. Milone, Steven Nichtberger, and Aimee Payne in April 2017 and is headquartered in Philadelphia, PA.